You don't know that (another large CREZ project) you are just speculating this is the case.
To prove my point about stocks moving prior to news I present 2 of the biggest small cap winners in 2012 and the news flow
First BDSI up 670% last year from $.84 to $6.45
This was written in March stock already at $2.35 so almost a triple off the low. The news actually is negative discussing delays.
Potential Catalyst price movers:
Recently, BDSI had an issue rolling out Onsolis, which is an opioid analgesic indicated only for the management of breakthrough pain in patients with cancer, 18 years of age and older, who are already receiving, and who are tolerant to opioid therapy for their underlying persistent cancer pain.
On Mar 12, 2012 BDSI announced Onsolis distribution was being postponed until the product formulation can be modified to address two appearance issues raised by the FDA following a recent inspection of the Aveva manufacturing facility where Onsolis is produced.
Anticipation for the rollout of Onsolis to actually occur should give BDSI some upward price movement.
So what happened to the stock price? It stayed in the $2.30 range for the month of March and then went to $4.30 15 days into April. So what was the news? It came in late April
Following the decision of the US patent and trademark office to extend the patent protection of BioDelivery Sciences International’s (BDSI) pain candidate BEMA buprenorphine by seven years to 2027, partner Endo Pharmaceuticals (ENDP) will pay $15 million as milestone payment to BioDelivery Sciences.
We remind investors that in January 2012, Endo Pharma had inked a global license and development agreement with BioDelivery Sciences regarding the latter’s pain candidate BEMA buprenorphine. Per the terms of the deal, Endo is responsible for the manufacturing, distribution and commercialization of the candidate on a worldwide basis.
By this time BDSI has already moved from $.84 to $4.49. I think this one is obvious as to my point of movement ahead of news.
Lets look at another big winner Elli up 405%
It went from $5.11 to $28 Jan to August 2012
On Feb 24 2012 there was this:
Ellie Mae Inc., the mortgage- software company, surged to its highest since it first sold shares to the public in April on strong fourth-quarter earnings and reports that signal the housing market is stabilizing.
Ellie Mae rose 13 percent to $8.98 at the close of NYSE Amex trading. The Pleasanton, California-based provider of mortgage-origination software and services offered stock at $6 a share in April 2011.
This is their Fourth Quarter results....reported Feb 23
Ellie Mae Reports Fourth Quarter and Fiscal Year 2011 Results
Fourth quarter 2011 revenue up 48% year over year to $18.8 million
2011 revenue up 28% year over year to $55.5 million
2011 adjusted net income up 52% year over year to $4.9 million, or $0.24 per diluted share
PLEASANTON, Calif.--(BUSINESS WIRE)--Feb. 23, 2012-- Ellie Mae® (NYSE Amex:ELLI), a leading provider of on-demand, enterprise level automated solutions for the residential mortgage industry, today reported results for the fourth quarter and fiscal year ended December 31, 2011.
Strong numbers but ELLI already moved from $5 to $9 ahead of this. FRom there it tripled
May results
Ellie Mae Reports First Quarter 2012 Results
Revenue up 97% year over year to $20.9 million
PLEASANTON, Calif., May 02, 2012 (BUSINESS WIRE) --Ellie Mae®(NYSE Amex:ELLI), a leading provider of on-demand, enterprise level automated solutions for the residential mortgage industry, today reported results for the first quarter ended March 31, 2012.
Total revenue for the first quarter of 2012 increased 97% to $20.9 million, compared to $10.6 million in the first quarter of 2011. Net income for the first quarter of 2012 was $3.6 million, or $0.16 per diluted share, compared to a net loss of $(0.8) million, or $(0.22) per diluted share, in the first quarter of 2011.
Finally the next quarter results on aug 1
Ellie Mae Reports Second Quarter 2012 Results
Revenue up 106% year over year to $23.6 million
PLEASANTON, Calif.--(BUSINESS WIRE)--Aug. 1, 2012-- Ellie Mae® (NYSE: ELLI), a leading provider of on-demand, enterprise level automation solutions for the residential mortgage industry, today reported results for the second quarter and six months ended June 30, 2012.
Total revenue for the second quarter of 2012 increased 106% to $23.6 million, compared to $11.5 million in the second quarter of 2011. Net income for the second quarter of 2012 was $5.0 million, or $0.21 per diluted share, compared to a net loss of $(40) thousand, or $(0.00) per diluted share, in the second quarter of 2011.
So basically this company had strong earnings that just kept getting better. I think GV will be able to show this even without a new contract announcement. However as I said I looked at the CREZ operation and there is so much work available I would be shocked if they did not land at least one more contract or more.
I see GV continuing to go higher on expectation of positive news from earnings and a possible new contract or two. There are very few shares outstanding and only 1.1 million shares owned by institutions as of 9/30 I expect this number to be much higher when the December quarter gets announced next week.
AI
Market Data 
Markets 
